Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Jennifer L, Christensen"'
Autor:
Samuel L, Aitken, M Jahangir, Alam, Mohammed, Khaleduzzaman, Mohammed, Khaleduzzuman, Seth T, Walk, William L, Musick, Vy P, Pham, Jennifer L, Christensen, Robert L, Atmar, Yang, Xie, Kevin W, Garey
Publikováno v:
Infection Control & Hospital Epidemiology. 36:1318-1323
BACKGROUNDConflicting reports have been published on the association between Clostridium difficile ribotypes and severe disease outcomes in patients with C. difficile infection (CDI); several so-called hypervirulent ribotypes have been described. We
Autor:
Eugénie Bassères, Bradley T. Endres, Mohammed Khaleduzzaman, Julie Kuo, William L. Musick, Seth T. Walk, M. Jahangir Alam, Kevin W. Garey, Jennifer L. Christensen, Robert L. Atmar, Jonathan Amadio
Publikováno v:
Open Forum Infectious Diseases. 4
Background Clostridium difficile infection is often considered to result from recent acquisition of a C difficile isolate in a healthcare setting. However, C difficile spores can persist for long periods of time, suggesting a potentially large commun
Autor:
M Jahangir, Alam, Seth T, Walk, Bradley T, Endres, Eugenie, Basseres, Mohammed, Khaleduzzaman, Jonathan, Amadio, William L, Musick, Jennifer L, Christensen, Julie, Kuo, Robert L, Atmar, Kevin W, Garey
Publikováno v:
Open Forum Infectious Diseases
Background. Clostridium difficile infection is often considered to result from recent acquisition of a C difficile isolate in a healthcare setting. However, C difficile spores can persist for long periods of time, suggesting a potentially large commu
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 302:502-509
Morphine tolerance in vivo is reduced following blockade of the orphanin FQ/nociceptin (OFQ/N)/opioid receptor-like 1 (ORL1) receptor system, suggesting that OFQ/N contributes to the development of morphine tolerance. We previously reported that a 60
Publikováno v:
Leukemia research. 32(3)
Over-expression of P-glycoprotein (Pgp+) has been related to resistance to classical Topo II inhibitors used in the treatment of AML and is common in patients with poor-prognosis, such as those with secondary AML (sAML). Since clinical trials with am
Publikováno v:
Microfluidic Technologies for Miniaturized Analysis Systems ISBN: 9780387285979
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::462a5ea7f4025fce60d169e7218d2ef0
https://doi.org/10.1007/978-0-387-68424-6_10
https://doi.org/10.1007/978-0-387-68424-6_10